Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Medexus Pharmaceuticals Inc (MEDXF)

Medexus Pharmaceuticals Inc (MEDXF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Medexus Holds Annual and Special Meeting of Shareholders and Announces Election of Board of Directors

Medexus Pharmaceuticals Inc. (the "Company") (TSX: MDP) (OTCQX: MEDXF) today held its annual and special meeting of shareholders virtually. At the meeting, all of the nominees listed in the Company's management...

MDP.TO : 3.11 (-4.60%)
MEDXF : 2.4400 (-4.31%)
Medexus Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF) today announced that Ken d'Entremont, Chief Executive Officer of Medexus, and Marcel Konrad, Chief Financial Officer...

MDP.TO : 3.11 (-4.60%)
MEDXF : 2.4400 (-4.31%)
Medexus Pharmaceuticals Reports Financial and Operational Results for First Quarter Fiscal 2022

Continued strength in unit demand across key product lines

MDP.TO : 3.11 (-4.60%)
MEDXF : 2.4400 (-4.31%)
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021

The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor...

ACOG.VN : 1.700 (-3.95%)
GET.CN : 0.300 (-9.09%)
MYID.VN : 0.340 (-8.11%)
OSS.VN : 0.650 (+4.84%)
TBRD.VN : 4.350 (-2.25%)
VMC.VN : 5.150 (-6.53%)
VST.CN : 0.455 (-5.21%)
WTEQ.CN : 0.110 (-8.33%)
XXII : 2.86 (-5.92%)
AYRO : 3.37 (-7.42%)
BCDA : 2.97 (-4.66%)
BLGO : 0.1735 (-5.71%)
BITF : 4.42 (-13.67%)
BAMM.CN : 0.570 (-6.56%)
BMMJ : 0.4507 (-4.11%)
BCTX : 7.15 (-9.03%)
BCTXW : 2.86 (-6.23%)
BTX : 9.94 (-16.82%)
CURR : 0.7000 (-1.41%)
DN.TO : 0.3900 (-1.27%)
DLTNF : 0.3000 (-3.01%)
SOLO : 3.29 (-7.58%)
ELLXF : 0.0720 (-14.29%)
FRSAF : 0.0120 (unch)
FLGC : 5.19 (-17.88%)
GMETF : 0.2300 (-2.79%)
GBLX : 0.0360 (unch)
GOVX : 4.31 (-8.10%)
GTMS.TO : 10.67 (-5.32%)
GBNH : 8.53 (-3.62%)
IFA.TO : 3.30 (unch)
IFABF : 2.5600 (-9.54%)
INND : 0.0098 (-2.00%)
ILAL : 0.8297 (+2.43%)
ISDR : 25.68 (-5.50%)
KSPN : 16.20 (-4.74%)
MYIDF : 0.2682 (-4.08%)
LEAF.TO : 3.00 (-3.23%)
LEMLF : 2.2900 (-5.27%)
LXXGF : 0.3517 (-9.82%)
LTBR : 4.74 (-5.39%)
MDP.TO : 3.11 (-4.60%)
MEDXF : 2.4400 (-4.31%)
OSSIF : 0.5077 (+1.95%)
ORGS : 4.89 (-3.74%)
PTPI : 1.96 (+4.81%)
PRPH : 4.99 (-1.96%)
MAPPF : 0.3064 (-1.98%)
PYR : 4.19 (-5.20%)
PYR.TO : 5.35 (-5.64%)
LUKEF : 0.2300 (unch)
RCRT : 3.63 (+0.83%)
RCRTW : 1.3200 (-2.94%)
RIII : 0.0340 (+1.80%)
SPVNF : 1.0758 (-8.46%)
STAF : 2.00 (-2.91%)
SPCB : 0.9768 (-6.97%)
TGCB : 0.6500 (-13.33%)
TEKCF : 0.4750 (+14.35%)
TFFP : 7.84 (-1.98%)
THBRF : 3.3601 (-4.00%)
VENZF : 0.0594 (-1.00%)
VEV : 4.01 (-7.60%)
VSQTF : 0.3541 (-5.97%)
VIRI : 5.38 (+4.94%)
VMAR : 6.52 (-4.82%)
VNRX : 3.09 (-2.52%)
WTEQF : 0.0868 (-4.51%)
WPNDF : 0.9439 (-3.19%)
XSF.CN : 0.170 (-10.53%)
XSHLF : 0.1408 (+5.07%)
ZIVO : 5.09 (+81.79%)
Medexus Completes Enrollment in Phase 4 Clinical Trial of IXINITY(R) Targeting Label Expansion for Pediatric Hemophilia B Patients

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSX: MDP) (OTCQX: MEDXF) today announced that is has completed enrollment in its Phase 4 Clinical Trial of IXINITY, targeting label expansion...

MDP.TO : 3.11 (-4.60%)
MEDXF : 2.4400 (-4.31%)
Medexus Schedules First Quarter Fiscal 2022 Conference Call

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSX: MDP) (OTCQX: MEDXF) today announced that it plans to host a conference call at 8:00 AM Eastern Time on Tuesday, August 17, 2021 to discuss...

MDP.TO : 3.11 (-4.60%)
MEDXF : 2.4400 (-4.31%)
Medexus to Present at Canaccord Genuity's 41st Annual Growth Conference

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSX: MDP) (OTCQX: MEDXF) announced today that it will be presenting at the Canaccord Genuity 41 Annual Growth Conference being held virtually...

MDP.TO : 3.11 (-4.60%)
MEDXF : 2.4400 (-4.31%)
Medexus Schedules Webinar to Discuss FDA Complete Response Letter for Treosulfan

Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF) today announced that it has scheduled a webinar on Thursday, August 5, 2021 at 10:00 a.m. Eastern Time to discuss the...

MDP.TO : 3.11 (-4.60%)
MEDXF : 2.4400 (-4.31%)
Complete Response Letter Received from FDA for Treosulfan

Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF) and medac GmbH ("medac") announced today that medac, Medexus' licensor for treosulfan, has received a Complete Response...

MDP.VN : 7.750 (-4.91%)
MDP.TO : 3.11 (-4.60%)
MEDXF : 2.4400 (-4.31%)
Medexus Appoints New Chief Financial Officer

Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the appointment of Marcel Konrad as Chief Financial Officer of the Company, effective immediately....

MDP.VN : 7.750 (-4.91%)
MDP.TO : 3.11 (-4.60%)
MEDXF : 2.4400 (-4.31%)
CDNA : 62.95 (-7.39%)

Barchart Exclusives

Meats Experience Seasonal Weakness After A Bullish WASDE report
It is the offseason for animal protein demand, and prices have been moving lower over the past weeks. Meanwhile, the latest WASDE report was not bearish for beef and pork prices. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar